EUVIMEDSkopri EUVIMED
Crossref

HLA‐A*11:01 and HLA‐C*03 Binding to FKBP1A Influences the Efficacy of Tacrolimus in Myasthenia Gravis Subgroups

Yuanzhi Lv, Kangzhi Chen iD, Mengchuan Luo, Yuzhen Ouyang, Kailin Li, Zhaohui Luo iD, Huan Yang iD

HLA · 2026-04 · 107 (4)

DOI: 10.1111/tan.70697 ↗

At a glance

Journal article in HLA, published online on 2026-04-02. Written by Yuanzhi Lv and 6 co-authors. Institution: Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Major MEDLINE topics: Tacrolimus, Myasthenia Gravis, HLA-C Antigens, HLA-A Antigens. 49 references. Funded by: National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Tacrolimus (TAC) is recommended for the patients with drug tolerance or respond poorly to other conventional immunosuppressants in myasthenia gravis (MG), but its effectiveness is influenced by dose and genetic polymorphism. Studies suggest that HLA polymorphisms are significantly associated with susceptibility to MG, but the relationship between HLA and TAC efficacy in MG has not been explored. In this paper, we investigated the correlation between TAC therapeutic efficacy and HLA in different MG subgroups. HLA‐C*03 was associated with a better response to TAC in patients with early‐onset MG, generalized MG, and those with a high concentration of TAC. While HLA‐A*11:01 showed poor responsiveness to TAC in generalized MG. Furthermore, computational docking was used to demonstrate the binding situation of HLA‐A with the TAC binding protein FKBP1A. It showed that HLA‐A*11:01 had a higher binding strength with FKBP1A than HLA‐C*03 , indicating that the combination of different types of HLA and FKBP1A may be one of the reasons affecting its therapeutic efficacy. This study highlights the influence of HLA on the efficacy of TAC among different MG subgroups, providing clues for precise treatment of MG with TAC.

Subjects

MeSH terms (MEDLINE)

TacrolimusMyasthenia GravisHLA-C AntigensHLA-A AntigensTacrolimus Binding Protein 1AImmunosuppressive AgentsHumansFemaleProtein BindingMolecular Docking SimulationMaleAdultMiddle AgedTacrolimus Binding Proteins

Author keywords

HLAclinical efficacymyasthenia gravistacrolimus

Substances

TacrolimusHLA-C AntigensHLA-A AntigensTacrolimus Binding Protein 1AFKBP1A protein, humanImmunosuppressive AgentsTacrolimus Binding Proteins

Authors and institutions

  • Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Clinical Research Center for Epileptic Disease of Hunan Province, Central South University, Changsha, China.
  • Department of Neurology, Xiangya Hospital, Central South University, Jiangxi (National Regional Center for Neurological Diseases), Nanchang, China.
  • Research Center for Neuroimmune and Neuromuscular Disorders, Xiangya Hospital, Central South University, Changsha, China.

ORCID profiles: Kangzhi Chen, Zhaohui Luo, Huan Yang

Funding

  • National Natural Science Foundation of China

Cite

APA

Lv, Y., Chen, K., Luo, M., Ouyang, Y., Li, K., Luo, Z., & Yang, H. (2026). HLA‐A*11:01 and HLA‐C*03 Binding to FKBP1A Influences the Efficacy of Tacrolimus in Myasthenia Gravis Subgroups. HLA, 107(4). https://doi.org/10.1111/tan.70697

Vancouver

Lv Y, Chen K, Luo M, Ouyang Y, Li K, Luo Z, et al. HLA‐A*11:01 and HLA‐C*03 Binding to FKBP1A Influences the Efficacy of Tacrolimus in Myasthenia Gravis Subgroups. HLA. 2026;107(4). doi:10.1111/tan.70697

BibTeX
@article{Lv2026,
  author = {Lv, Yuanzhi and Chen, Kangzhi and Luo, Mengchuan and Ouyang, Yuzhen and Li, Kailin and Luo, Zhaohui and Yang, Huan},
  title = {HLA‐A*11:01 and HLA‐C*03 Binding to FKBP1A Influences the Efficacy of Tacrolimus in Myasthenia Gravis Subgroups},
  journal = {HLA},
  year = {2026},
  volume = {107},
  number = {4},
  doi = {10.1111/tan.70697}
}
Start for free →